Bioavailability of Aciclovir after Oral Administration of Aciclovir and Its Prodrug Valaciclovir to Patients with Leukopenia after Chemotherapy
The median bioavailabilities of aciclovir after administration of aciclovir and its prodrug valaciclovir were 21.5 and 70.1%, respectively, in 12 patients with malignant hematological diseases with leukopenia after chemotherapy. The interindividual variations of the bioavailability were 48.5 and 21....
Na minha lista:
| 發表在: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society for Microbiology (ASM)
2000
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89657/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10602752/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.1.207-209.2000 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|